XML 26 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Restricted Stock Units (RSUs)
Common Stock
Common Stock
Restricted Stock Units (RSUs)
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interests
Beginning Balance (in Shares) at Dec. 31, 2014     37,360,515          
Beginning Balance at Dec. 31, 2014 $ 645,085   $ 374   $ 217,289 $ 433,641 $ (24,669) $ 18,450
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (7,990)         (8,067)   77
Issuance of common stock upon stock option exercises, including tax benefit (in shares) 209,205   209,205          
Issuance of common stock upon stock option exercises, including tax benefit $ 2,466   $ 2   2,464      
Restricted shares issued (in Shares)       12,646        
Issuance of shares pursuant to deferred stock unit awards (in Shares)     27,779          
Forfeitures of restricted shares (in Shares)     (54,045)          
Forfeitures of restricted shares (1)   $ (1)          
Shares repurchased and retired (in Shares)     (1,502,601)          
Shares repurchased and retired (27,803)   $ (14)   (27,789)      
Equity-based compensation expense 7,987       7,987      
Investment by non-controlling interests 239             239
Purchase of non-controlling interests 472             472
Currency translation adjustment and derivative transactions, net (24,955)           (23,192) (1,763)
Ending Balance (in Shares) at Dec. 31, 2015     36,053,499          
Ending Balance at Dec. 31, 2015 594,556   $ 361   199,951 425,574 (47,861) 16,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 29,160         29,488   (328)
Issuance of common stock upon stock option exercises, including tax benefit (in shares) 114,307   114,307          
Issuance of common stock upon stock option exercises, including tax benefit $ 1,818   $ 1   1,817      
Restricted shares issued (in Shares)       141,507        
Restricted shares issued   $ 1   $ 1        
Issuance of shares pursuant to deferred stock unit awards (in Shares)     39,660          
Forfeitures of restricted shares (in Shares)     (42,775)          
Shares repurchased and retired (in Shares)     (2,349,894)          
Shares repurchased and retired (44,454)   $ (23)   (44,431)      
Equity-based compensation expense 9,261       9,261      
Sale of non-controlling interest (7,278)             (7,278)
Distributions to non-controlling interests (1,276)             (1,276)
Currency translation adjustment and derivative transactions, net $ (5,605)           (5,639) 34
Ending Balance (in Shares) at Dec. 31, 2016 33,956,304   33,956,304          
Ending Balance at Dec. 31, 2016 $ 576,183   $ 340   166,598 455,062 (53,500) 7,683
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (66,235)         (69,054)   2,819
Issuance of common stock upon stock option exercises, including tax benefit (in shares) 43,573   43,573          
Issuance of common stock upon stock option exercises, including tax benefit $ 822       822      
Restricted shares issued (in Shares)       95,510        
Restricted shares issued   $ 1   $ 1        
Issuance of shares pursuant to performance units (in Shares)     49,672          
Issuance of shares pursuant to deferred stock unit awards (in Shares)     30,559          
Forfeitures of restricted shares (in Shares)     (1,084)          
Shares repurchased and retired (in Shares)     (1,711,992)          
Shares repurchased and retired (37,849)   $ (16)   (37,833)      
Equity-based compensation expense 11,162       11,162      
Investment by non-controlling interests 158             158
Distributions to non-controlling interests (71)             (71)
Currency translation adjustment and derivative transactions, net $ 20,885           20,664 221
Ending Balance (in Shares) at Dec. 31, 2017 32,462,542   32,462,542          
Ending Balance at Dec. 31, 2017 $ 505,056   $ 325   $ 140,749 $ 386,008 $ (32,836) $ 10,810